Table 5.
Attitude of healthcare providers towards ADR reporting in Mizan Tepi University Teaching Hospital from August to September 2021.
| Variables | N (%) | ||||
|---|---|---|---|---|---|
| Strongly agree | Agree | Neutral | Disagree | Strongly disagree | |
| ADR reporting is duty of health professionals | 115 (60.5) | 65 (34.2) | 3 (1.6) | 5 (2.6) | 2 (1.1) |
| ADRs need to be sure before reporting | 79 (41.6) | 96 (50.5) | 4 (2.1) | 10 (5.3) | 1 (0.5) |
| ADR report improves patient's safety | 81 (42.6) | 86 (45.3) | 11 (5.8) | 11 (5.8) | 1 (0.5) |
| All suspected ADRs should be reported | 39 (20.5) | 56 (29.5) | 47 (24.7) | 46 (24.2) | 2 (1.1) |
| ADR reporting trends identify relatively safe drugs | 45 (23.7) | 92 (48.4) | 33 (17.4) | 17 (8.9) | 3 (1.6) |
| ADR reporting creates workload | 21 (11.1) | 37 (19.5) | 49 (25.8) | 72 (37.9) | 11 (5.8) |
| ADR reporting is not important for the healthcare system | 12 (6.3) | 23 (12.1) | 18 (9.5) | 82 (43.2) | 55 (28.9) |
| Reporting of ADR affects patient's confidentiality issues | 15 (7.9) | 35 (18.4) | 31 (16.3) | 85 (44.7) | 24 (12.6) |
| A single ADR report brings no difference | 10 (5.3) | 22 (11.6) | 37 (19.5) | 93 (48.9) | 28 (14.7) |
| Fear of legal liability affects ADR reporting | 32 (16.8) | 40 (21.1) | 37 (19.5) | 66 (34.7) | 15 (7.9) |